Aims and Scope
European Urology Oncology is the new sister journal to European Urology and European Urology Focus, and the first official publication of the EAU fully devoted to the study of genitourinary malignancies.
Key Metrics
9.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.87 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Surgery
SJR
- Q1 Surgery
- Q1 Urology
- Q2 Oncology
- Q1 Radiology, Nuclear Medicine and Imaging
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
2.02
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Urology
- Prostate cancer
- Prostatectomy
- Overall survival
- Magnetic resonance imaging
- Clinical significance
- Immunotherapy
- Germ cell tumors
- Renal carcinoma
- Bladder cancer
- Data system
- Photodynamic therapy
- Positron emission tomography
- Prostate-specific antigen
- Positron emission
- Randomized controlled trial
- Lymph node
- Immune checkpoint inhibitors
- Salvage radiotherapy
- Testicular cancer
Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2018 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in European urology oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Contents
- 1 Apr 24
- European Urology Oncology
-
Full paper
Contents
- 1 Apr 24
- European Urology Oncology
-
Full paper
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508–15
- 1 Nov 23
- European Urology Oncology
-
Full paper
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
- 1 Nov 23
- European Urology Oncology
-
Full paper
Metastatic Organotropism Differential Treatment Response in Urothelial Carcinoma: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
- 1 Nov 23
- European Urology Oncology
Scite analysis
Powered by scite_
0.9k articles received 8.2k citations see all
- 332 Supporting
- 7,660 Mentioning
- 49 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 6 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
27%
4 to 6 months
55%
7 to 9 months
12%
Above 9 months
6%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has European urology oncology been actively publishing?
European urology oncology has been in operation since 2018 till date.
What is the publishing frequency of European urology oncology ?
European urology oncology published with a Bi-monthly frequency.
How many articles did European urology oncology publish last years ?
In 2023, European urology oncology published 3 articles.
What is the eISSN & pISSN for European urology oncology ?
For European urology oncology,eISSN is 2588-9311 and pISSN is2588-9311.
What is Citescore for European urology oncology ?
Citescore for European urology oncology is 9.4.
What is SNIP score for European urology oncology ?
SNIP score for European urology oncology is 2.02.
What is the SJR for European urology oncology ?
SJR for European urology oncology is Q2.
Who is the publisher of European urology oncology ?
ELSEVIER is the publisher of European urology oncology.